Skip to main content
PMC home page
British Journal of Cancer logoLink to British Journal of Cancer
. 2001 Sep 1;85(9):1412–1417. doi: 10.1054/bjoc.2001.2105

Establishment of two new human bladder carcinoma cell lines, CAL 29 and CAL 185. Comparative study of cell scattering and epithelial to mesenchyme transition induced by growth factors

N Cattan 1, N Rochet 2, C Mazeau 1, E Zanghellini 1, B Mari 3, C Chauzy 4, H Stora de Novion 5, J Amiel 6, J-L Lagrange 7, B Rossi 2, J Gioanni 1
PMCID: PMC2375255  PMID: 11720483

Abstract

We describe here two new human urothelial carcinoma cell lines, CAL 29 and CAL 185, established from two patients with high-grade tumours and which display very different properties in vitro. We have shown that CAL 29 cells were tumorigenic in mice and expressed characteristic features of both cell scattering and transition from epithelial to mesenchymal phenotype (EMT) after triggering by the EGF receptor ligands, TGFα and EGF. At the opposite, the CAL 185 cells were not tumorigenic in mice and neither scattered nor expressed vimentin intermediary filaments in the presence of growth factors. We further demonstrated that CAL 29 cell scattering was reversible after growth factor removal and that both scattering and EMT were markedly impaired after treatment with MEK, Src and PI3-kinase inhibitors suggesting that these kinases might be important components of the cellular responses to EGF and TGF-α leading to scattering and EMT. These agents could help to understand the intracellular pathways involved in invasiveness and to find new targets for limiting metastasis. In conclusion, these two new cell lines could be good models to dissect the molecular mechanisms involved in invasion and metastasis development in human bladder cancer. © 2001 Cancer Research Campaign  http://www.bjcancer.com

Keywords: bladder carcinoma, cell scattering, EMT, EFGR ligands

Full Text

The Full Text of this article is available as a PDF (108.8 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Birchmeier C., Birchmeier W., Brand-Saberi B. Epithelial-mesenchymal transitions in cancer progression. Acta Anat (Basel) 1996;156(3):217–226. doi: 10.1159/000147848. [DOI] [PubMed] [Google Scholar]
  2. Boyer B., Roche S., Denoyelle M., Thiery J. P. Src and Ras are involved in separate pathways in epithelial cell scattering. EMBO J. 1997 Oct 1;16(19):5904–5913. doi: 10.1093/emboj/16.19.5904. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Boyer B., Tucker G. C., Vallés A. M., Franke W. W., Thiery J. P. Rearrangements of desmosomal and cytoskeletal proteins during the transition from epithelial to fibroblastoid organization in cultured rat bladder carcinoma cells. J Cell Biol. 1989 Oct;109(4 Pt 1):1495–1509. doi: 10.1083/jcb.109.4.1495. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Boyer B., Tucker G. C., Vallés A. M., Gavrilovic J., Thiery J. P. Reversible transition towards a fibroblastic phenotype in a rat carcinoma cell line. Int J Cancer Suppl. 1989;4:69–75. doi: 10.1002/ijc.2910440719. [DOI] [PubMed] [Google Scholar]
  5. Cooper C. S., See W. A. The impact of iatrogenic urothelial trauma on urinary levels of transforming growth factor-alpha. J Urol. 1992 Jun;147(6):1647–1649. doi: 10.1016/s0022-5347(17)37670-x. [DOI] [PubMed] [Google Scholar]
  6. Dutrillaux B., Lejeune J. Sur une nouvelle technique d'analyse du caryotype humain. C R Acad Sci Hebd Seances Acad Sci D. 1971 May 17;272(20):2638–2640. [PubMed] [Google Scholar]
  7. Gavrilović J., Moens G., Thiery J. P., Jouanneau J. Expression of transfected transforming growth factor alpha induces a motile fibroblast-like phenotype with extracellular matrix-degrading potential in a rat bladder carcinoma cell line. Cell Regul. 1990 Dec;1(13):1003–1014. doi: 10.1091/mbc.1.13.1003. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Gilles C., Polette M., Piette J., Delvigne A. C., Thompson E. W., Foidart J. M., Birembaut P. Vimentin expression in cervical carcinomas: association with invasive and migratory potential. J Pathol. 1996 Oct;180(2):175–180. doi: 10.1002/(SICI)1096-9896(199610)180:2<175::AID-PATH630>3.0.CO;2-G. [DOI] [PubMed] [Google Scholar]
  9. Hay E. D. An overview of epithelio-mesenchymal transformation. Acta Anat (Basel) 1995;154(1):8–20. doi: 10.1159/000147748. [DOI] [PubMed] [Google Scholar]
  10. Imai T., Kimura M., Takeda M., Tomita Y. Significance of epidermal growth factor receptor and c-erbB-2 protein expression in transitional cell cancer of the upper urinary tract for tumour recurrence at the urinary bladder. Br J Cancer. 1995 Jan;71(1):69–72. doi: 10.1038/bjc.1995.14. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Khwaja A., Lehmann K., Marte B. M., Downward J. Phosphoinositide 3-kinase induces scattering and tubulogenesis in epithelial cells through a novel pathway. J Biol Chem. 1998 Jul 24;273(30):18793–18801. doi: 10.1074/jbc.273.30.18793. [DOI] [PubMed] [Google Scholar]
  12. Lochter A., Galosy S., Muschler J., Freedman N., Werb Z., Bissell M. J. Matrix metalloproteinase stromelysin-1 triggers a cascade of molecular alterations that leads to stable epithelial-to-mesenchymal conversion and a premalignant phenotype in mammary epithelial cells. J Cell Biol. 1997 Dec 29;139(7):1861–1872. doi: 10.1083/jcb.139.7.1861. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Mellon J. K., Cook S., Chambers P., Neal D. E. Transforming growth factor alpha and epidermal growth factor levels in bladder cancer and their relationship to epidermal growth factor receptor. Br J Cancer. 1996 Mar;73(5):654–658. doi: 10.1038/bjc.1996.114. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Petit V., Boyer B., Lentz D., Turner C. E., Thiery J. P., Vallés A. M. Phosphorylation of tyrosine residues 31 and 118 on paxillin regulates cell migration through an association with CRK in NBT-II cells. J Cell Biol. 2000 Mar 6;148(5):957–970. doi: 10.1083/jcb.148.5.957. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Petit V., Boyer B., Thiery J. P., Vallés A. M. Characterization of the signaling pathways regulating alpha2beta1 integrin-mediated events by a pharmacological approach. Cell Adhes Commun. 1999;7(3):151–165. doi: 10.3109/15419069909010799. [DOI] [PubMed] [Google Scholar]
  16. Ravery V., Colombel M., Popov Z., Bastuji S., Patard J. J., Bellot J., Abbou C. C., Fradet Y., Chopin D. K. Prognostic value of epidermal growth factor-receptor, T138 and T43 expression in bladder cancer. Br J Cancer. 1995 Jan;71(1):196–200. doi: 10.1038/bjc.1995.40. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Ruck A., Paulie S. EGF, TGF alpha, AR and HB-EGF are autocrine growth factors for human bladder carcinoma cell lines. Anticancer Res. 1998 May-Jun;18(3A):1447–1452. [PubMed] [Google Scholar]
  18. Savagner P., Vallés A. M., Jouanneau J., Yamada K. M., Thiery J. P. Alternative splicing in fibroblast growth factor receptor 2 is associated with induced epithelial-mesenchymal transition in rat bladder carcinoma cells. Mol Biol Cell. 1994 Aug;5(8):851–862. doi: 10.1091/mbc.5.8.851. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Thiery J. P., Chopin D. Epithelial cell plasticity in development and tumor progression. Cancer Metastasis Rev. 1999;18(1):31–42. doi: 10.1023/a:1006256219004. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES